Evidence map›Paper›PMID 41650957›Full record

ArticleStem cell reports2026

Generating high-quality porcine iPSCs with the new medium cocktail LACID.

Bingbo Shi, Jiajun Li, Xiaomin Wang, Dong Liu, Jinzhu Xiang, Hanning Wang, Changjiang Xu, Xinle Zou, Zhuangfei Wang, Tao Huang and 7 more

Abstract read
In one paragraph

Article in Stem cell reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Bingbo ShiLaboratory of Cell Fate Control, School of Life Sciences, Westlake University, Hangzhou, China; Centre for Regenerative Medicine and Health, Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences, Hong Kong, China.
Jiajun LiLaboratory of Cell Fate Control, School of Life Sciences, Westlake University, Hangzhou, China; Fudan University, Shanghai, China.
Xiaomin WangLaboratory of Cell Fate Control, School of Life Sciences, Westlake University, Hangzhou, China.
Dong LiuLaboratory of Cell Fate Control, School of Life Sciences, Westlake University, Hangzhou, China.
Jinzhu XiangLaboratory of Cell Fate Control, School of Life Sciences, Westlake University, Hangzhou, China.
Hanning WangLaboratory of Cell Fate Control, School of Life Sciences, Westlake University, Hangzhou, China.
Changjiang XuLaboratory of Cell Fate Control, School of Life Sciences, Westlake University, Hangzhou, China.
Xinle ZouLaboratory of Cell Fate Control, School of Life Sciences, Westlake University, Hangzhou, China.
Zhuangfei WangLaboratory of Cell Fate Control, School of Life Sciences, Westlake University, Hangzhou, China.
Tao HuangLaboratory of Cell Fate Control, School of Life Sciences, Westlake University, Hangzhou, China; College of Life Sciences, Zhejiang University, Hangzhou, China.
Qiankun MinLaboratory of Cell Fate Control, School of Life Sciences, Westlake University, Hangzhou, China.
Kaipeng WangLaboratory of Cell Fate Control, School of Life Sciences, Westlake University, Hangzhou, China; Fudan University, Shanghai, China.
Yihang YangLaboratory of Cell Fate Control, School of Life Sciences, Westlake University, Hangzhou, China.
Junyang LiLaboratory of Cell Fate Control, School of Life Sciences, Westlake University, Hangzhou, China.
Bo WangZhejiang University of Science and Technology, School of Information and Electronic Engineering, Hangzhou, China; Key Laboratory of Biomedical Intelligent Computing Technology of Zhejiang Province, Hangzhou, China. Electronic address: wangbo@westlake.edu.cn.
Chengchen ZhaoWestlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China; Laboratory of Cell Fate Control, School of Life Sciences, Westlake University, Hangzhou, China; Key Laboratory of Biomedical Intelligent Computing Technology of Zhejiang Province, Hangzhou, China. Electronic address: zhaochengchen@westlake.edu.cn.
Duanqing PeiLaboratory of Cell Fate Control, School of Life Sciences, Westlake University, Hangzhou, China; Centre for Regenerative Medicine and Health, Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences, Hong Kong, China; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China. Electronic address: peiduanqing@westlake.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pigs are important for disease model generation, xenotransplantation, and interspecies organogenesis. Porcine induced pluripotent stem cells (piPSCs) should enable these efforts, but have not been generated to meet the attributes, such as feeder-free culture, robust development potential, and blastocyst generation through nuclear transfer. We report an improved strategy to generate such piPSCs. We show that chemically defined medium 3 promotes the formation of epithelium-like colonies in porcine reprogramming, which allows further reprogramming under the new medium cocktail LACID. The resulting piPSCs have key features, including flat morphology with feeder-free culture, generating robust teratoma and blastoids, forming chimeric blastocysts, and readily edited with CRISPR-Cas9. Lastly, nuclear transfer with piPSCs can develop into blastocysts. Despite maintaining a primed pluripotent state, our results suggest that the newly established LACID piPSCs may be ideal for applications in regenerative medicine. This method may be further improved to generate naive or totipotent stem cells.

Indexed as

Cell Culture TechniquesCulture MediaInduced Pluripotent Stem CellsAnimalsBlastocystCell DifferentiationCells, CulturedCellular ReprogrammingNuclear Transfer TechniquesSwineCulture Mediablastoidsfeeder-freeinduced iPS chemically defined medium 3LACIDnuclear transferporcine induced pluripotent stem cells

Identifiers

PMID41650957
PMCPMC12985392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.